Business Wire 

Omdia: Global Cloud Infrastructure Spending Hits $102.6 Billion, up 25% in Q3 2025

LONDON --(BUSINESS WIRE) According to new research from Omdia, global spending on cloud infrastructure services reached $102.6 billion in Q3 2025, representing 25% year-on-year growth. Market momentum remained stable,...

Omdia: Global Cloud Infrastructure Spending Hits $102.6 Billion, up 25% in Q3 2025
Axelspace: Notice of Signing a Service contract for In-Orbit Demonstration with Pale Blue, Inc.

TOKYO --(BUSINESS WIRE) Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” has entered into a service agreement with Pale Blue Inc. (“Pale Blue”), a company...

Axelspace: Notice of Signing a Service contract for In-Orbit Demonstration with Pale Blue, Inc.
Axelspace Signing Agreement on a Multi-Launch Arrangement and the Launch of New Satellites with Exolaunch

TOKYO --(BUSINESS WIRE) Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” is pleased to announce a multi-launch agreement (MLA) with Exolaunch, a global...

Axelspace Signing Agreement on a Multi-Launch Arrangement and the Launch of New Satellites with Exolaunch
The Most Iconic Moments From Lily Allen, Lewis Capaldi, Katy Perry and Drake Revealed in Year in Live Experiences Report

LONDON --(BUSINESS WIRE) From Lily Allen creating the ultimate diss album, Lewis Capaldi beating Drake and Kendrick, to Katy Perry’s space adventure impacting her ticket sales - a new report unlocks fans favourite moments...

The Most Iconic Moments From Lily Allen, Lewis Capaldi, Katy Perry and Drake Revealed in Year in Live Experiences Report
Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor

Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor

Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor
Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma

Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for Relapsed/Refractory Follicular Lymphoma

Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma
ENHERTU® Granted Breakthrough Therapy Designation in the U.S. as Post-Neoadjuvant Therapy for Patients with HER2 Positive Early Breast Cancer

ENHERTU® Granted Breakthrough Therapy Designation in the U.S. as Post-Neoadjuvant Therapy for Patients with HER2 Positive Early Breast Cancer

ENHERTU® Granted Breakthrough Therapy Designation in the U.S. as Post-Neoadjuvant Therapy for Patients with HER2 Positive Early Breast Cancer
DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer

DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer

DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer
JAB Insurance to Enter UK Life and Pension Market With Acquisition of Utmost Group’s Life and Pensions Business

MIAMI --(BUSINESS WIRE) JAB Insurance today announced that it has entered into a definitive agreement to acquire from Utmost Group plc its Life and Pensions business (“ULP”), a UK life and pensions platform with more than...

JAB Insurance to Enter UK Life and Pension Market With Acquisition of Utmost Group’s Life and Pensions Business
Coty Appoints Markus Strobel Executive Chairman and Interim CEO

NEW YORK --(BUSINESS WIRE) Regulatory News:

Coty Appoints Markus Strobel Executive Chairman and Interim CEO
Mitsubishi Electric Invests in Tulip Interfaces And Signs Strategic Alliance Agreement

Will leverage no-code operations platform to strengthen DX solutions for manufacturing and beyond

Mitsubishi Electric Invests in Tulip Interfaces And Signs Strategic Alliance Agreement
Number of Shares and Voting Rights of Innate Pharma as of December 18, 2025

MARSEILLE, France --(BUSINESS WIRE) Regulatory News:

Number of Shares and Voting Rights of Innate Pharma as of December 18, 2025
GenSight Biologics Announces the Granting of Compassionate Use Authorization (CUA/AAC) for GS010/LUMEVOQ® in France

French medicines agency ANSM has granted authorization for named patient early access program for GS010/LUMEVOQ®, a gene therapy indicated for the treatment of ND4-LHON.

GenSight Biologics Announces the Granting of Compassionate Use Authorization (CUA/AAC) for GS010/LUMEVOQ® in France
e.l.f. Cosmetics Extends Partnership with The Wonder Women of Wrestling Foundation

e.l.f. doubles down on the fastest-growing high school sport to expand access, visibility and opportunity for the next generation of women athletes

e.l.f. Cosmetics Extends Partnership with The Wonder Women of Wrestling Foundation
QAD | Redzone Marks 20 Years in India by Honoring 2025 Champions of Change Driving the Future of Manufacturing

Industry leaders recognized for execution, scale, and measurable outcomes as India emerges as a global engine for manufacturing transformation

QAD | Redzone Marks 20 Years in India by Honoring 2025 Champions of Change Driving the Future of Manufacturing
Hisense Joins HEVC Advance Patent Pool

Access Advance LLC today announced that Hisense Group Holdings Co., Ltd. has joined the HEVC Advance Patent Pool as a Licensee.

Hisense Joins HEVC Advance Patent Pool
CWAN Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Clearwater Analytics Holdings, Inc. is Fair to Shareholders

Shareholders should contact the firm as there may be limited time to enforce your rights.

CWAN Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Clearwater Analytics Holdings, Inc. is Fair to Shareholders
Nidec Announces the Resignation and Change in Title of a Representative Director and Member of the Board of Director

KYOTO, Japan --(BUSINESS WIRE) Nidec Corporation (TOKYO: 6594; OTC US: NJDCY) (the “Company”) today announced the resignation of a Representative Director and member of the Board of Director of the Company, and a change in...

Nidec Announces the Resignation and Change in Title of a Representative Director and Member of the Board of Director
Textron Aviation Defense Secures First Contract to Deliver Beechcraft T-6 Texan II Integrated Training System to Japan

Textron Aviation Defense awarded contract to deliver Beechcraft T-6JP Texan II integrated training system to Japan’s Air Self-Defense Force (JASDF).

Textron Aviation Defense Secures First Contract to Deliver Beechcraft T-6 Texan II Integrated Training System to Japan
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at The Wildermuth Fund

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In The Wildermuth Fund To Contact Him Directly To Discuss Their Options

SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at The Wildermuth Fund
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Synopsys

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Synopsys To Contact Him Directly To Discuss Their Options

SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Synopsys
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at James Hardie

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In James Hardie To Contact Him Directly To Discuss Their Options

SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at James Hardie
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Sprouts Farmers Market

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Sprouts To Contact Him Directly To Discuss Their Options

SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Sprouts Farmers Market
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Alexandria Real Estate Equities

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Alexandria To Contact Him Directly To Discuss Their Options

SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Alexandria Real Estate Equities
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Tvardi To Contact Him Directly To Discuss Their Options

TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Telix Pharmaceuticals

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Telix To Contact Him Directly To Discuss Their Options

SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Telix Pharmaceuticals
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Gauzy

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Gauzy To Contact Him Directly To Discuss Their Options

SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Gauzy
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Blue Owl Capital

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Blue Owl To Contact Him Directly To Discuss Their Options

SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Blue Owl Capital
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Rezolute To Contact Him Directly To Discuss Their Options

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Inspire Medical Systems

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inspire Medical To Contact Him Directly To Discuss Their Options

SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Inspire Medical Systems
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Freeport-McMoran

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Freeport-McMoran To Contact Him Directly To Discuss Their Options

SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Freeport-McMoran
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Stride

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Stride To Contact Him Directly To Discuss Their Options

SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Stride
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at DeFi Technologies

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In DeFi Technologies To Contact Him Directly To Discuss Their Options

SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at DeFi Technologies
NJDCY INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nidec

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Nidec To Contact Him Directly To Discuss Their Options

NJDCY INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nidec
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at StubHub

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In StubHub To Contact Him Directly To Discuss Their Options

SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at StubHub
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Bitdeer Technologies

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Bitdeer To Contact Him Directly To Discuss Their Options

SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Bitdeer Technologies
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Primo Brands

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Primo Brands To Contact Him Directly To Discuss Their Options

SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Primo Brands
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Firefly Aerospace

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Firefly Aerospace To Contact Him Directly To Discuss Their Options

SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Firefly Aerospace
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Firefly Aerospace

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Firefly Aerospace To Contact Him Directly To Discuss Their Options

SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Firefly Aerospace
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Avantor

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered In Avantor To Contact Him Directly To Discuss Their Options

SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Avantor
Fluor to Divest its Zhuhai Fabrication Yard in China

Fluor to Divest its Zhuhai Fabrication Yard in China

Fluor to Divest its Zhuhai Fabrication Yard in China